<SEC-DOCUMENT>0001437749-26-020373.txt : 20260612
<SEC-HEADER>0001437749-26-020373.hdr.sgml : 20260612
<ACCEPTANCE-DATETIME>20260612060748
ACCESSION NUMBER:		0001437749-26-020373
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20260630
FILED AS OF DATE:		20260612
DATE AS OF CHANGE:		20260612

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ALTERITY THERAPEUTICS LTD
		CENTRAL INDEX KEY:			0001131343
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				000000000
		STATE OF INCORPORATION:			C3
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-49843
		FILM NUMBER:		261084835

	BUSINESS ADDRESS:	
		ADDRESS IS A NON US LOCATION: 	YES
		STREET 1:		LEVEL 3, 460 BOURKE STREET
		CITY:			MELBOURNE
		PROVINCE COUNTRY:   	C3
		BUSINESS PHONE:		61 3 9349 4906

	MAIL ADDRESS:	
		ADDRESS IS A NON US LOCATION: 	YES
		STREET 1:		LEVEL 3, 460 BOURKE STREET
		CITY:			MELBOURNE
		PROVINCE COUNTRY:   	C3

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PRANA BIOTECHNOLOGY LTD
		DATE OF NAME CHANGE:	20010105
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>athe20260612_6k.htm
<DESCRIPTION>FORM 6-K
<TEXT>
<html><head>
	<title>athe20260612_6k.htm</title>
	<!-- Generated by ThunderDome Portal - 6/12/2026 6:58:23 AM --><meta charset="utf-8"><meta name="format-detection" content="telephone=no">
</head>
<body style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; padding: 0in 0.1in; cursor: auto;">
<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Washington, D.C. 20549</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>FORM 6-K</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>REPORT OF FOREIGN PRIVATE ISSUER</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>PURSUANT TO RULE 13a-16 OR 15d-163</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>UNDER THE SECURITIES EXCHANGE ACT OF 1934</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>For the month of June&nbsp;2026</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Alterity Therapeutics Limited</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(Name of Registrant)</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Level 15, 500 Collins Street, Melbourne, Victoria 3000 Australia</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(Address of Principal Executive Office)</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Form 20-F &#9746;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Form 40-F &#9744;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><b>This Form 6-K is being incorporated by reference into our Registration Statement on Form S-8 (Files No. </b><a href="http://www.sec.gov/Archives/edgar/data/1131343/000121390020040485/ea130838-s8_alteritytherape.htm" style="-sec-extract:exhibit;"><b><u>333-251073</u></b></a><b>, </b><a href="http://www.sec.gov/Archives/edgar/data/1131343/000121390020027969/ea127207-s8_alteritytherap.htm" style="-sec-extract:exhibit;"><b><u>333-248980</u></b></a><b> and </b><a href="http://www.sec.gov/Archives/edgar/data/1131343/000114420418063081/tv508429_s-8.htm" style="-sec-extract:exhibit;"><b><u>333-228671</u></b></a><b>) and our Registration Statements on Form F-3 (Files No. </b><a href="http://www.sec.gov/Archives/edgar/data/1131343/000101376223000033/ea185947-f3_alteritytherape.htm" style="-sec-extract:exhibit;"><b><u>333-274816</u></b></a><b>, </b><a href="http://www.sec.gov/Archives/edgar/data/1131343/000121390020044324/ea132148-f3_alteritytherape.htm" style="-sec-extract:exhibit;"><b><u>333-251647</u></b></a><b>, </b><a href="http://www.sec.gov/Archives/edgar/data/1131343/000114420419025615/tv521271_f3.htm" style="-sec-extract:exhibit;"><b><u>333-231417</u></b></a><b> and </b><a href="http://www.sec.gov/Archives/edgar/data/1131343/000121390020036934/ea129831-f3_alteritytherap.htm" style="-sec-extract:exhibit;"><b><u>333-250076</u></b></a><b>)</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<div contenteditable="false" data-applyto="p" data-auto-pgnum="start" data-displaynum="1" data-fontname="Times New Roman" data-fontsize="10pt" data-numstyle="a" data-prefix="" data-startnum="1" data-suffix="" data-textalign="center">&nbsp;</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>ALTERITY THERAPEUTICS LIMITED</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>(a development stage enterprise)</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The following exhibits are submitted:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">99.1</p>
			</td>
			<td style="width: auto;"><a href="ex_976191.htm" style="-sec-extract:exhibit;">Completion of Consolidation</a></td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="1" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">1</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><u>SIGNATURE</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:top;width:auto;">&nbsp;</td>
			<td colspan="2" style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Alterity Therapeutics Limited</b></p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:32.1%;">&nbsp;</td>
			<td style="vertical-align:top;width:2.1%;">&nbsp;</td>
			<td style="vertical-align:top;width:19.2%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:auto;">&nbsp;</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">By:</p>
			</td>
			<td style="vertical-align: top; width: auto; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">/s/ Julian Babarczy</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:auto;">&nbsp;</td>
			<td style="vertical-align:top;width:auto;">&nbsp;</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Julian Babarczy</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:auto;">&nbsp;</td>
			<td style="vertical-align:top;width:auto;">&nbsp;</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Chairman</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Date: June 12, 2026</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="2" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">2</div>
</div>
</div>
</div>


</body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ex_976191.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html><head>
	<title>ex_976191.htm</title>
	<!-- Generated by ThunderDome Portal - 6/12/2026 7:01:10 AM --><meta charset="utf-8"><meta name="format-detection" content="telephone=no">
</head>
<body style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; padding: 0in 0.1in; cursor: auto;">
<p style="margin: 0px 0pt; text-align: right; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt"><b>Exhibit 99.1</b></font></p>

<p style="margin: 0px 0pt; text-align: left; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>

<p style="text-align:center;font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><img alt="logo.jpg" src="logo.jpg"></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:12pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;"><b>Completion of Consolidation of Capital</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b style="font-size: 10pt;">MELBOURNE, AUSTRALIA AND SAN FRANCISCO, USA </b>&#8211;&nbsp;<b style="font-size: 10pt;">12 June 2026:&nbsp;</b><u>Alterity Therapeutics</u> (ASX: ATH, NASDAQ: ATHE) (&#8220;Alterity&#8221; or &#8220;the Company&#8221;), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, advises that the consolidation of the Company&#8217;s issued capital on a fifty (50) to one (1) basis, as approved by shareholders at the General Meeting on 29 May 2026, has now been completed.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">The Company&#8217;s post-consolidation capital structure is as follows:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 17.7%; border-width: 1px; border-style: solid; border-color: black;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;"><b>ASX CODE</b></p>
			</td>
			<td style="vertical-align: top; width: 63.7%; border-top: 1px solid black; border-bottom: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;"><b>QUOTED SECURITIES</b></p>
			</td>
			<td style="vertical-align: top; width: 26.8%; border-width: 1px; border-style: solid; border-color: black;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;"><b>NUMBER</b></p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 17.7%; border-left: 1px solid black; border-right: 1px solid black; border-bottom: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;">ATH</p>
			</td>
			<td style="vertical-align: top; width: 63.7%; border-bottom: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;">Ordinary fully paid shares</p>
			</td>
			<td style="vertical-align: top; width: 26.8%; border-left: 1px solid black; border-right: 1px solid black; border-bottom: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;">217,508,862</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 17.7%; border-left: 1px solid black; border-right: 1px solid black; border-bottom: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;">ATHO</p>
			</td>
			<td style="vertical-align: top; width: 63.7%; border-bottom: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;">Option expiring 31-Aug-2026 ex $0.50</p>
			</td>
			<td style="vertical-align: top; width: 26.8%; border-left: 1px solid black; border-right: 1px solid black; border-bottom: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;">18,624,729</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 17.7%; border-left: 1px solid black; border-right: 1px solid black; border-bottom: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;">ATHOA</p>
			</td>
			<td style="vertical-align: top; width: 63.7%; border-bottom: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;">Option expiring 26-Feb-2027 ex $1.40</p>
			</td>
			<td style="vertical-align: top; width: 26.8%; border-left: 1px solid black; border-right: 1px solid black; border-bottom: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;">24,446,043</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 17.7%; border-left: 1px solid black; border-right: 1px solid black; border-bottom: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;"><b>ASX CODE</b></p>
			</td>
			<td style="vertical-align: top; width: 63.7%; border-bottom: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;"><b>UNQUOTED SECURITIES</b></p>
			</td>
			<td style="vertical-align: top; width: 26.8%; border-left: 1px solid black; border-right: 1px solid black; border-bottom: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;"><b>NUMBER</b></p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 17.7%; border-left: 1px solid black; border-right: 1px solid black; border-bottom: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;">ATHAA</p>
			</td>
			<td style="vertical-align: top; width: 63.7%; border-bottom: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;">Option expiring 13-Mar-2029 ex $0.20</p>
			</td>
			<td style="vertical-align: top; width: 26.8%; border-left: 1px solid black; border-right: 1px solid black; border-bottom: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;">403,334</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 17.7%; border-left: 1px solid black; border-right: 1px solid black; border-bottom: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;">ATHAAE</p>
			</td>
			<td style="vertical-align: top; width: 63.7%; border-bottom: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;">Option expiring 29-Nov-2026 ex $1.875</p>
			</td>
			<td style="vertical-align: top; width: 26.8%; border-left: 1px solid black; border-right: 1px solid black; border-bottom: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;">200,000</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 17.7%; border-left: 1px solid black; border-right: 1px solid black; border-bottom: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;">ATHAAG</p>
			</td>
			<td style="vertical-align: top; width: 63.7%; border-bottom: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;">Option expiring 29-Nov-2026 ex $1.19</p>
			</td>
			<td style="vertical-align: top; width: 26.8%; border-left: 1px solid black; border-right: 1px solid black; border-bottom: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;">230,000</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 17.7%; border-left: 1px solid black; border-right: 1px solid black; border-bottom: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;">ATHAAH</p>
			</td>
			<td style="vertical-align: top; width: 63.7%; border-bottom: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;">Option expiring 19-Dec-2026 ex $0.525</p>
			</td>
			<td style="vertical-align: top; width: 26.8%; border-left: 1px solid black; border-right: 1px solid black; border-bottom: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;">160,000</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 17.7%; border-left: 1px solid black; border-right: 1px solid black; border-bottom: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;">ATHAAK</p>
			</td>
			<td style="vertical-align: top; width: 63.7%; border-bottom: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;">Option expiring 30-Dec-2027 ex $0.50</p>
			</td>
			<td style="vertical-align: top; width: 26.8%; border-left: 1px solid black; border-right: 1px solid black; border-bottom: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;">3,400,000</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 17.7%; border-left: 1px solid black; border-right: 1px solid black; border-bottom: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;">ATHAAL</p>
			</td>
			<td style="vertical-align: top; width: 63.7%; border-bottom: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;">Option expiring 09-Jan-2031 ex $0.40</p>
			</td>
			<td style="vertical-align: top; width: 26.8%; border-left: 1px solid black; border-right: 1px solid black; border-bottom: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;">360,000</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 17.7%; border-left: 1px solid black; border-right: 1px solid black; border-bottom: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;">ATHAAM</p>
			</td>
			<td style="vertical-align: top; width: 63.7%; border-bottom: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;">Option expiring 13-Jan-2031 ex USD 0.285</p>
			</td>
			<td style="vertical-align: top; width: 26.8%; border-left: 1px solid black; border-right: 1px solid black; border-bottom: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;">870,000</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 17.7%; border-left: 1px solid black; border-right: 1px solid black; border-bottom: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;">ATHAB</p>
			</td>
			<td style="vertical-align: top; width: 63.7%; border-bottom: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;">Option expiring 13-Mar-2029 ex USD 0.155</p>
			</td>
			<td style="vertical-align: top; width: 26.8%; border-left: 1px solid black; border-right: 1px solid black; border-bottom: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;">1,250,000</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 17.7%; border-left: 1px solid black; border-right: 1px solid black; border-bottom: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;">ATHAC</p>
			</td>
			<td style="vertical-align: top; width: 63.7%; border-bottom: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;">Option expiring 21-Mar-2029 ex USD 0.15</p>
			</td>
			<td style="vertical-align: top; width: 26.8%; border-left: 1px solid black; border-right: 1px solid black; border-bottom: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;">800,004</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 17.7%; border-left: 1px solid black; border-right: 1px solid black; border-bottom: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;">ATHAD</p>
			</td>
			<td style="vertical-align: top; width: 63.7%; border-bottom: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;">Option expiring 01-Jul-2030 ex $0.50</p>
			</td>
			<td style="vertical-align: top; width: 26.8%; border-left: 1px solid black; border-right: 1px solid black; border-bottom: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;">300,000</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 17.7%; border-left: 1px solid black; border-right: 1px solid black; border-bottom: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;">ATHAE</p>
			</td>
			<td style="vertical-align: top; width: 63.7%; border-bottom: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;">Option expiring 08-Aug-2030 ex $0.65</p>
			</td>
			<td style="vertical-align: top; width: 26.8%; border-left: 1px solid black; border-right: 1px solid black; border-bottom: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;">230,000</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 17.7%; border-left: 1px solid black; border-right: 1px solid black; border-bottom: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;">ATHAF</p>
			</td>
			<td style="vertical-align: top; width: 63.7%; border-bottom: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;">Option expiring 08-Aug-2030 ex USD 0.43</p>
			</td>
			<td style="vertical-align: top; width: 26.8%; border-left: 1px solid black; border-right: 1px solid black; border-bottom: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;">6,248,004</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 17.7%; border-left: 1px solid black; border-right: 1px solid black; border-bottom: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;">ATHAG</p>
			</td>
			<td style="vertical-align: top; width: 63.7%; border-bottom: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;">Option expiring 26-Mar-2031 ex USD 0.285</p>
			</td>
			<td style="vertical-align: top; width: 26.8%; border-left: 1px solid black; border-right: 1px solid black; border-bottom: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;">1,230,000</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 17.7%; border-left: 1px solid black; border-right: 1px solid black; border-bottom: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;">ATHAJ</p>
			</td>
			<td style="vertical-align: top; width: 63.7%; border-bottom: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;">Option expiring 15-Apr-2031 ex USD 0.302</p>
			</td>
			<td style="vertical-align: top; width: 26.8%; border-left: 1px solid black; border-right: 1px solid black; border-bottom: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;">4,245,000</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 17.7%; border-left: 1px solid black; border-right: 1px solid black; border-bottom: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;">ATHAK</p>
			</td>
			<td style="vertical-align: top; width: 63.7%; border-bottom: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;">Option expiring 15-Apr-2031 ex $0.45</p>
			</td>
			<td style="vertical-align: top; width: 26.8%; border-left: 1px solid black; border-right: 1px solid black; border-bottom: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;">540,000</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">Where the consolidation process resulted in a fraction of a share, any fractional entitlements have been rounded up to the nearest whole number (to a minimum of 1 security).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">Holding statements have been despatched to all shareholders and option holders advising them of their holdings on a post-consolidation basis.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">Normal trading (on a T+2 settlement basis) commenced today, Friday 12 June, under ASX code &#8220;ATH&#8221;.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><b>Authorised for release by the Board of Directors of Alterity Therapeutics Limited.</b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><b style="font-size: 10pt;">About Alterity Therapeutics Limited</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">Alterity Therapeutics is a clinical stage biotechnology company dedicated to creating an alternate future for people living&nbsp;with neurodegenerative diseases. The Company is focused on developing disease modifying therapies in Multiple System Atrophy (MSA) and related Parkinsonian disorders. Alterity is preparing to initiate a Phase 3 pivotal trial in MSA, a rare and rapidly progressive disease. ATH434, the Company&#8217;s lead asset, has demonstrated clinically meaningful efficacy in a randomized, double-blind, placebo-controlled Phase 2 clinical trial in participants with MSA. Alterity has further reported positive data in its open label Phase 2 clinical trial in participants with advanced MSA. In addition, Alterity has a broad drug discovery platform generating patentable chemical compounds to treat the underlying pathology of neurological diseases. The Company is based in Melbourne, Australia, and San Francisco, California, USA. For further information please visit the Company&#8217;s website at <u>www.alteritytx.com</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><b>Contacts:</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><b>Investors</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">Elyse Shapiro</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><u>ir@alteritytx.com</u></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">Remy Bernarda</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">Investor Relations Advisory Solutions</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><u>ir@alteritytx.com</u></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">+1 (415) 203-6386</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><b>Media</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">Casey McDonald</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">Tiberend Strategic Advisors, Inc.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><u>cmcdonald@tiberend.com</u></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">+1 (646) 577-8520</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>
</div>


</body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>logo.jpg
<TEXT>
begin 644 logo.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1"  U -P# 2(  A$! Q$!_\0
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M*G>'?%NI^ M)\1:=!X/O([.[&K0)&9'<,5*;6/'RYKZH#<<D9[TIQY-& M%
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MRRQ16MR^W[%K=IG?#MZ9DC##/<JHK>M#VE#5W:*.H_X/%S_QDI\ ?^P==?\
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M7 9\._V9M$^%WQ[^('Q#LKK49M7^)'V$:A#-(#!!]DB:./RQCC(/->7^(_\
M@G-92_%77O&'@3XB^/OA>/%]XNH>)-*T&YB^PZS<#;NGV2(QAE=0%9XR":**
MI,#U#XY_!G4OC?X,L=.TGQQXI\!WUK*EU#J6BR1&8@#:8I4E1DE0YR0R]:\K
M^$7_  3-^&?P8T;4K:_@U7Q?K6MZE-K&JZQJ-UY-Q?W4P7>Y2 )&O"KPJ@<4
(45<-78:1_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
